Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine RecipientsAlana F. Ogata, David R. Walt, Chi‐An Cheng et al.|Clinical Infectious Diseases|2021Cited by 236
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignanciesJennifer L. Crombie, Nicolas C. Issa, Jonathan Krauß et al.|Blood Advances|2021Cited by 24
Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and ReactogenicityAmy C Sherman, Lindsey R. Baden, Michaël Desjardins et al.|Clinical Infectious Diseases|2021Cited by 24
Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid MalignanciesAmy C Sherman, Nicolas C. Issa, Jennifer L. Crombie et al.|Open Forum Infectious Diseases|2022Cited by 10
586. Immunogenicity of COVID-19 mRNA Vaccines in Patients with Lymphoid MalignanciesNatalie Izaguirre, Lindsey R. Baden, Amy C Sherman et al.|Open Forum Infectious Diseases|2021Cited by 1